SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals-Reference-Cited by-同舟云学术

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

Published:2021-06 Issue:6 Volume:24 Page:102646
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Coyle Peter V.,Chemaitelly Hiam^ORCID,Ben Hadj Kacem Mohamed Ali^ORCID,Abdulla Al Molawi Naema Hassan,El Kahlout Reham Awni,Gilliani Imtiaz,Younes Nourah,Al Anssari Ghada Ali A.A.,Al Kanaani Zaina,Al Khal Abdullatif^ORCID,Al Kuwari Einas,Butt Adeel A.,Jeremijenko Andrew^ORCID,Kaleeckal Anvar Hassan,Latif Ali Nizar^ORCID,Shaik Riyazuddin Mohammad,Abdul Rahim Hanan F.,Nasrallah Gheyath K.,Yassine Hadi M.,Al Kuwari Mohamed Ghaith,Al Romaihi Hamad Eid,Al-Thani Mohamed H.,Bertollini Roberto,Abu-Raddad Laith J.^ORCID

Funder

Hamad Medical Corporation

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference34 articles.

1. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic;Abu-Raddad;Sci. Rep.,2021

2. Abu-Raddad, L.J., Chemaitelly, H., Ayoub, H.H., Coyle, P., Malek, J.A., Ahmed, A.A., Mohamoud, Y.A., Younuskunju, S., Tang, P., Kanaani, Z.A., et al 2021b. Epidemiologic Characterization of Introduction and Expansion of the SARS-CoV-2 B.1.1.7 Variant and its Reinfections in a National Population. Under review.

3. SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks;Abu-Raddad;E Clin. Med.,2021

4. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting;Abu-Raddad;Clin. Infect. Dis.,2020

5. Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020;Al Kuwari;BMJ Open,2020

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 infection prevalence, risk factors, and outcomes among non-clinical-related service providers in a national healthcare system;Global Epidemiology;2024-12

2. Assessing Healthy Vaccinee Effect in COVID-19 Vaccine Effectiveness Studies: A National Cohort Study in Qatar;2024-07-29

3. Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient;Vaccine;2024-05

4. Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation;Frontiers in Medicine;2024-03-11

5. Anti-SARS-CoV-2 Antibody Response Among Spectators of Amir Cup 2020 With a History of Recovery From COVID-19 in Qatar: A Historic Cohort Study;Cureus;2024-02-18